Robert Sikorski - Concepedia

Author

Robert Sikorski

Johns Hopkins Medicine

Also Known As

R Sikorski, ROBERT S. SIKORSKI, Robert S. Sikorski, Robert Sikorski

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins Medicine Johns Hopkins University Five Prime Therapeutics (United States)National Cancer Institute Amgen (United States)

About

Robert Sikorski is an author at Johns Hopkins Medicine specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	3.8K
2	Natural Sciences	4	4	3.6K
3	Engineering	1	1	1.7K
4	Health Sciences	1	1	14
5	Public Health	1	1	10

Robert Sikorski

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2008	3.1K
Towards a proteome-scale map of the human protein–protein interaction network Jean‐François Rual, K. Venkatesan, Tong Hao, Nature Proteomic TechnologyInteractomicsMedicineNatural SciencesProtein Analysis	2005	3K
Multifunctional yeast high-copy-number shuttle vectors Thomas Christianson, Robert Sikorski, Michael Dante, Gene EngineeringBiotechnologyMolecular BiologySynthetic BiologyYeast	1992	1.7K
[20] In vitro mutagenesis and plasmid shuffling: From cloned gene to mutant yeast Robert Sikorski, Jef D. Boeke Methods in enzymology on CD-ROM/Methods in enzymology Natural SciencesGeneticsPlasmid ShufflingMolecular BiologyGenetic Engineering	1991	587
A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis Robert Sikorski, Mark S. Boguski, Mark Goebl, Cell	1990	503
A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS). Kamalesh K. Sankhala, Jean‐Yves Blay, Kristen N. Ganjoo, Journal of Clinical Oncology Anti-csf1r AntibodyVillonodular Synovitis D-pvnsImmunologyImmunoeditingPathology	2017	42
Sun-Related Risk Factors in Melanoma-Prone Families With CDKN2A Mutations Alisa M. Goldstein, Mary C. Fraser, Margaret A. Tucker, JNCI Journal of the National Cancer Institute Tumor BiologyPhotocarcinogenesisMelanomaDermatologyMedicine	1998	37
Human p53 and <i>CDC2Hs</i> Genes Combine To Inhibit the Proliferation of <i>Saccharomyces cerevisiae</i> Janice Nigro, Robert Sikorski, Steven I. Reed, Molecular and Cellular Biology Pronounced Growth InhibitionGeneticsCell DeathMolecular BiologyCell Proliferation	1992	30
Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Journal of Clinical Oncology	2023	27
Oncology ASAP Robert Sikorski JAMA Cancer EducationMedicineDear SirCancer ManagementShark Cartilage	1997	23

Page 1